文献速递头颈外科

临床T1-2、N0期声门上型鳞状细胞癌患者的表现与结局:根治性放疗与原发性部分喉切除术的比较

Presentation and outcomes of patients with clinically T1-2, N0 supraglottic squamous cell carcinoma: The role of definitive radiotherapy compared to primary partial laryngectomy.
PubMed 文献 · Head Neck · 2021-12-29

基于美国国家癌症数据库2010-2016年的回顾性分析,纳入3301例临床T1-2、N0期声门上型鳞状细胞癌成人患者,比较根治性放疗与部分喉切除术联合择区性颈清扫的结局。放疗占93.52%,开放部分喉切除联合颈清扫占2.64%,机器人辅助部分喉切除联合颈清扫占1.33%,内镜手术切除占2.51%。手术组中23.36%的患者T分期上调、16.36%的患者N分期上调;原发手术组与放疗组的5年生存率分别为61.89%与77.46%(HR 0.56,95%CI 0.43-0.72)。

要点

  • 手术组中23.36%的患者T分期上调、16.36%的患者N分期上调
  • 原发手术组与放疗组的5年生存率分别为61.89%与77.46%(HR 0.56,95%CI 0.43-0.72)
  • 作者认为放疗患者可能遗漏准确分期,或导致该治疗组总生存较低

核心结论

  • 手术患者中T分期上调者占23%;作者认为接受放疗的患者可能遗漏这种准确分期,并可能 contribuir 至该治疗组总生存较低。

研究设计与样本

  • 回顾性分析美国国家癌症数据库2010-2016年数据,纳入临床T1-2、N0期声门上型鳞状细胞癌成人患者3301例。

主要发现

  • 放疗占93.52%,开放部分喉切除联合择区性颈清扫占2.64%,机器人辅助部分喉切除联合择区性颈清扫占1.33%,内镜手术切除占2.51%。
  • 手术组中T分期上调者占23.36%,N分期上调者占16.36%。
  • 原发手术组与放疗组的5年生存率分别为61.89%与77.46%(HR 0.56,95%CI 0.43-0.72)。

关键数值与推荐

  • 原发手术组与放疗组5年生存率分别为61.89%与77.46%(HR 0.56,95%CI 0.43-0.72)。
  • 手术组T分期上调者占23.36%,N分期上调者占16.36%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early-stage supraglottic squamous cell carcinoma (SCC) is usually treated with a single modality. The aim of this study is to examine the role of radiotherapy (RT) versus partial laryngectomy (open, robotic-assisted, or endoscopic) with elective neck dissection (PL + END). METHODS: A retrospective analysis of the National Cancer Database, 2010-2016. The study population included adult patients with clinically T1-2, N0 supraglottic SCC. RESULTS: 3301 patients were included. RT was performed in 93.52%, open PL + END in 2.64%, robotic-assisted PL + END in 1.33%, and endoscopic surgical resection in 2.51%. In the surgery group, T was upstaged in 23.36% and N was upstage in 16.36%. Five-year survival in the primary surgery group compared to RT group was 61.89% versus 77.46% (HR: 0.56, 95%CI: 0.43, 0.72). CONCLUSIONS: T was upstaged in 23% of surgical patients. This accurate staging is likely missed in patients who undergo RT and possibly contributes to lower overall survival of this treatment group.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Al-Qurayshi Z, Ngouajio AL, Buchakjian MR, et al. Presentation and outcomes of patients with clinically T1-2, N0 supraglottic squamous cell carcinoma: The role of definitive radiotherapy compared to primary partial laryngectomy. Head Neck. 2021. PMID: 34964526. doi:10.1002/hed.26966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。